SPY453.42-3.98 -0.87%
DIA346.24-0.37 -0.11%
IXIC15,085.47-295.85 -1.92%

SVB Leerink Maintains Outperform on GoodRx Holdings, Lowers Price Target to $49

SVB Leerink analyst Stephanie Davis maintains GoodRx Holdings (NASDAQ:GDRX) with a Outperform and lowers the price target from $56 to $49.

Benzinga · 11/11/2021 05:00
SVB Leerink analyst Stephanie Davis maintains GoodRx Holdings (NASDAQ:GDRX) with a Outperform and lowers the price target from $56 to $49.